Europe Says<p><a href="https://www.europesays.com/2116322/" rel="nofollow noopener noreferrer" translate="no" target="_blank"><span class="invisible">https://www.</span><span class="">europesays.com/2116322/</span><span class="invisible"></span></a> ABO-Group shifts to large, multidisciplinary soil projects <a href="https://pubeurope.com/tags/ABO" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#<span>ABO</span></a> <a href="https://pubeurope.com/tags/AnnualGeneralMeeting" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#<span>AnnualGeneralMeeting</span></a> <a href="https://pubeurope.com/tags/belgium" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#<span>belgium</span></a> <a href="https://pubeurope.com/tags/Environment" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#<span>Environment</span></a> <a href="https://pubeurope.com/tags/EuronextBrussels" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#<span>EuronextBrussels</span></a> <a href="https://pubeurope.com/tags/EuronextParis" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#<span>EuronextParis</span></a> <a href="https://pubeurope.com/tags/InternationalCollaboration" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#<span>InternationalCollaboration</span></a> <a href="https://pubeurope.com/tags/MarketDemand" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#<span>MarketDemand</span></a> <a href="https://pubeurope.com/tags/MultidisciplinaryProjects" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#<span>MultidisciplinaryProjects</span></a></p>
Recherches récentes
Aucune recherche récente
Options de recherche
Disponible uniquement lorsque vous êtes connecté.
mastouille.fr est l'un des nombreux serveurs Mastodon indépendants que vous pouvez utiliser pour participer au fédiverse.
Mastouille est une instance Mastodon durable, ouverte, et hébergée en France.
Administré par :
Statistiques du serveur :
596comptes actifs
mastouille.fr: À propos · Annuaire des profils · Politique de confidentialité
Mastodon: À propos · Télécharger l’application · Raccourcis clavier · Voir le code source · v4.3.4
#Euronextparis
0 message · 0 participant · 0 message aujourd’hui
Europe Says<p><a href="https://www.europesays.com/2114884/" rel="nofollow noopener noreferrer" translate="no" target="_blank"><span class="invisible">https://www.</span><span class="">europesays.com/2114884/</span><span class="invisible"></span></a> Preliminary FY 20251 Revenues and Business Update <a href="https://pubeurope.com/tags/america" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#<span>america</span></a> <a href="https://pubeurope.com/tags/business" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#<span>business</span></a> <a href="https://pubeurope.com/tags/DigitalEclipse" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#<span>DigitalEclipse</span></a> <a href="https://pubeurope.com/tags/EuronextParis" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#<span>EuronextParis</span></a> <a href="https://pubeurope.com/tags/GrowthStrategy" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#<span>GrowthStrategy</span></a> <a href="https://pubeurope.com/tags/InteractiveEntertainment" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#<span>InteractiveEntertainment</span></a> <a href="https://pubeurope.com/tags/NightdiveStudios" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#<span>NightdiveStudios</span></a> <a href="https://pubeurope.com/tags/RollerCoasterTycoon" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#<span>RollerCoasterTycoon</span></a> <a href="https://pubeurope.com/tags/UnitedStates" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#<span>UnitedStates</span></a> <a href="https://pubeurope.com/tags/UnitedStatesOfAmerica" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#<span>UnitedStatesOfAmerica</span></a> <a href="https://pubeurope.com/tags/US" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#<span>US</span></a> <a href="https://pubeurope.com/tags/USA" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#<span>USA</span></a></p>
Bytes Europe<p>Air France-KLM Raises €500M in Oversubscribed Hybrid Bond Offering <a href="https://www.byteseu.com/1018107/" rel="nofollow noopener noreferrer" translate="no" target="_blank"><span class="invisible">https://www.</span><span class="">byteseu.com/1018107/</span><span class="invisible"></span></a> <a href="https://pubeurope.com/tags/AFLYY" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#<span>AFLYY</span></a> <a href="https://pubeurope.com/tags/AirFranceKLM" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#<span>AirFranceKLM</span></a> <a href="https://pubeurope.com/tags/AirlineFinancing" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#<span>AirlineFinancing</span></a> <a href="https://pubeurope.com/tags/BB" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#<span>BB</span></a>+Rating <a href="https://pubeurope.com/tags/BBBRating" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#<span>BBBRating</span></a> <a href="https://pubeurope.com/tags/CorporateBonds" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#<span>CorporateBonds</span></a> <a href="https://pubeurope.com/tags/CorporateRefinancing" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#<span>CorporateRefinancing</span></a> <a href="https://pubeurope.com/tags/EuronextParis" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#<span>EuronextParis</span></a> <a href="https://pubeurope.com/tags/FixedCoupon" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#<span>FixedCoupon</span></a> <a href="https://pubeurope.com/tags/France" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#<span>France</span></a> <a href="https://pubeurope.com/tags/HybridBonds" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#<span>HybridBonds</span></a> <a href="https://pubeurope.com/tags/OversubscribedBondOffering" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#<span>OversubscribedBondOffering</span></a> <a href="https://pubeurope.com/tags/SubordinatedDebt" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#<span>SubordinatedDebt</span></a></p>
Bytes Europe<p>Innate Pharma Reports First Quarter 2025 Business Update and Financial Results <a href="https://www.byteseu.com/1008997/" rel="nofollow noopener noreferrer" translate="no" target="_blank"><span class="invisible">https://www.</span><span class="">byteseu.com/1008997/</span><span class="invisible"></span></a> <a href="https://pubeurope.com/tags/AntibodyDrugConjugates" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#<span>AntibodyDrugConjugates</span></a> <a href="https://pubeurope.com/tags/AstraZeneca" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#<span>AstraZeneca</span></a> <a href="https://pubeurope.com/tags/business" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#<span>business</span></a> <a href="https://pubeurope.com/tags/ChiefExecutiveOfficer" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#<span>ChiefExecutiveOfficer</span></a> <a href="https://pubeurope.com/tags/company" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#<span>company</span></a> <a href="https://pubeurope.com/tags/EuronextParis" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#<span>EuronextParis</span></a> <a href="https://pubeurope.com/tags/InnatePharma" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#<span>InnatePharma</span></a> <a href="https://pubeurope.com/tags/JonathanDickinson" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#<span>JonathanDickinson</span></a> <a href="https://pubeurope.com/tags/Phase2ClinicalTrial" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#<span>Phase2ClinicalTrial</span></a> <a href="https://pubeurope.com/tags/Sanofi" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#<span>Sanofi</span></a> <a href="https://pubeurope.com/tags/TheCompany" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#<span>TheCompany</span></a></p>
Europe Says<p><a href="https://www.europesays.com/1888800/" rel="nofollow noopener noreferrer" translate="no" target="_blank"><span class="invisible">https://www.</span><span class="">europesays.com/1888800/</span><span class="invisible"></span></a> GTT receives an order for the tank design of two new LNG Carriers <a href="https://pubeurope.com/tags/ContainmentSystem" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#<span>ContainmentSystem</span></a> <a href="https://pubeurope.com/tags/EuronextParis" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#<span>EuronextParis</span></a> <a href="https://pubeurope.com/tags/GasPrice" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#<span>GasPrice</span></a> <a href="https://pubeurope.com/tags/GTT" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#<span>GTT</span></a> <a href="https://pubeurope.com/tags/LiquefiedNaturalGas" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#<span>LiquefiedNaturalGas</span></a> <a href="https://pubeurope.com/tags/lng" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#<span>lng</span></a> <a href="https://pubeurope.com/tags/LNGCarriers" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#<span>LNGCarriers</span></a> <a href="https://pubeurope.com/tags/LNGPrice" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#<span>LNGPrice</span></a> <a href="https://pubeurope.com/tags/NaturalGas" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#<span>NaturalGas</span></a></p>
Bytes Europe<p>Article from the leading publication Life Sciences Magazine featuring masitinib and its Phase 3 principal investigator, the neurologist Patrick Vermersch <a href="https://www.byteseu.com/798060/" rel="nofollow noopener noreferrer" translate="no" target="_blank"><span class="invisible">https://www.</span><span class="">byteseu.com/798060/</span><span class="invisible"></span></a> <a href="https://pubeurope.com/tags/ABScience" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#<span>ABScience</span></a> <a href="https://pubeurope.com/tags/AmyotrophicLateralSclerosis" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#<span>AmyotrophicLateralSclerosis</span></a> <a href="https://pubeurope.com/tags/BreakthroughTreatment" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#<span>BreakthroughTreatment</span></a> <a href="https://pubeurope.com/tags/EuronextParis" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#<span>EuronextParis</span></a> <a href="https://pubeurope.com/tags/InflammatoryDiseases" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#<span>InflammatoryDiseases</span></a> <a href="https://pubeurope.com/tags/MastCells" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#<span>MastCells</span></a> <a href="https://pubeurope.com/tags/microglia" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#<span>microglia</span></a> <a href="https://pubeurope.com/tags/MultipleSclerosis" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#<span>MultipleSclerosis</span></a> <a href="https://pubeurope.com/tags/neuroinflammation" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#<span>neuroinflammation</span></a> <a href="https://pubeurope.com/tags/Parkinson" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#<span>Parkinson</span></a>'sDisease <a href="https://pubeurope.com/tags/PATRICKVERMERSCH" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#<span>PATRICKVERMERSCH</span></a> <a href="https://pubeurope.com/tags/Science" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#<span>Science</span></a></p>
Europe Says<p><a href="https://www.europesays.com/1888321/" rel="nofollow noopener noreferrer" translate="no" target="_blank"><span class="invisible">https://www.</span><span class="">europesays.com/1888321/</span><span class="invisible"></span></a> Article from the leading publication Life Sciences Magazine featuring masitinib and its Phase 3 principal investigator, the neurologist Patrick Vermersch <a href="https://pubeurope.com/tags/ABSCIENCE" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#<span>ABSCIENCE</span></a> <a href="https://pubeurope.com/tags/america" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#<span>america</span></a> <a href="https://pubeurope.com/tags/AmyotrophicLateralSclerosis" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#<span>AmyotrophicLateralSclerosis</span></a> <a href="https://pubeurope.com/tags/BreakthroughTreatment" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#<span>BreakthroughTreatment</span></a> <a href="https://pubeurope.com/tags/EuronextParis" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#<span>EuronextParis</span></a> <a href="https://pubeurope.com/tags/InflammatoryDiseases" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#<span>InflammatoryDiseases</span></a> <a href="https://pubeurope.com/tags/MastCells" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#<span>MastCells</span></a> <a href="https://pubeurope.com/tags/microglia" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#<span>microglia</span></a> <a href="https://pubeurope.com/tags/MultipleSclerosis" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#<span>MultipleSclerosis</span></a> <a href="https://pubeurope.com/tags/neuroinflammation" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#<span>neuroinflammation</span></a> <a href="https://pubeurope.com/tags/Parkinson" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#<span>Parkinson</span></a>'sDisease <a href="https://pubeurope.com/tags/PATRICKVERMERSCH" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#<span>PATRICKVERMERSCH</span></a> <a href="https://pubeurope.com/tags/science" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#<span>science</span></a> <a href="https://pubeurope.com/tags/technology" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#<span>technology</span></a> <a href="https://pubeurope.com/tags/UnitedStates" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#<span>UnitedStates</span></a> <a href="https://pubeurope.com/tags/UnitedStatesOfAmerica" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#<span>UnitedStatesOfAmerica</span></a> <a href="https://pubeurope.com/tags/US" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#<span>US</span></a> <a href="https://pubeurope.com/tags/USA" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#<span>USA</span></a></p>
ExplorerFlux en direct
Mastodon est le meilleur moyen de suivre ce qui se passe.
Suivez n'importe qui à travers le fédivers et affichez tout dans un ordre chronologique. Ni algorithmes, ni publicités, ni appâts à clics en perspective.
Créer un compteSe connecterGlissez et déposez pour envoyer